戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 by monocyte-derived macrophages (both M1 and M2 macrophages).
2 red due to low binding affinity of M2pep for M2 macrophage.
3 age chemoattraction and differentiation into M2 macrophage.
4 s of chemokine mRNA and increased numbers of M2 macrophages.
5 e for mTORC2 signalling in the generation of M2 macrophages.
6 reduction in apoptotic M1, but not apoptotic M2 macrophages.
7   Administration of IL-4 is known to augment M2 macrophages.
8 ytokines and chemokines in the M1 versus the M2 macrophages.
9 chment in markers of alternatively activated M2 macrophages.
10 0-fold higher in M1 macrophages than that in M2 macrophages.
11 hage content and an enrichment in markers of M2 macrophages.
12 mmatory M1 macrophages and anti-inflammatory M2 macrophages.
13  by selective induction of anti-inflammatory M2 macrophages.
14 can program naive monocytes to polarize into M2 macrophages.
15 d a concomitant enhancement in arginase-1(+) M2 macrophages.
16  immune evasion by establishing residency in M2 macrophages.
17  and oxidative metabolism, characteristic of M2 macrophages.
18 tes, polarizing them toward tumor-supporting M2 macrophages.
19      No such trends were observed for CD163+ M2 macrophages.
20 out major effects on alternatively activated M2 macrophages.
21  to do so in the interleukin 4 (IL4)-induced M2 macrophages.
22 r cells (MDSCs), and alternatively activated M2 macrophages.
23 eported for AM HC-HA-PTX3 on polarization of M2 macrophages.
24 tases with the exception of CD4+ T cells and M2 macrophages.
25 +)/IL-31(+) macrophages and CD68(+)/CD163(+) M2 macrophages.
26 myeloid-derived suppressor cells (MDSC), and M2 macrophages.
27  TNF-alpha levels were 5x higher with M1 vs. M2 macrophages.
28 in macrophage gene expression in both M1 and M2 macrophages.
29 d a significant reduction of pro-tumorigenic M2 macrophages.
30 1 inhibitor 3887 suppresses SPM formation in M2 macrophages.
31 nds of the spectrum are classified as M1 and M2 macrophages.
32 cytic capacity than alternatively activated (M2) macrophages.
33 gh the induction of alternatively activated (M2) macrophages.
34 ors reduce leukotrienes in M1 but less so in M2 macrophages, 3) zileuton blocks resolution-initiating
35 is, together with disturbed proportion of M1/M2 macrophages, accompanied by enhanced formation of art
36                                 NAMPT-primed M2 macrophages activate extracellular-regulated kinase 1
37 d direct-acting antiviral therapy attenuated M2 macrophage activation and associated liver fibrosis.
38  induced by OVA, affecting Th2 inflammation, M2 macrophage activation and skin barrier function.
39 (OVA), we investigated Th2 immune responses, M2 macrophage activation and skin barrier gene expressio
40 icular fungal species in the gut and promote M2 macrophage activation at distant sites to influence s
41 ccompanied by a shift toward pro-tumorigenic M2 macrophage activation in Slc7a2-deficient mice, as ma
42  polarized these cells to adopt either M1 or M2 macrophage activation phenotypes.
43     The combined effect of restrained M1 and M2 macrophage activation resulted in decreased productio
44                               We showed that M2 macrophage activation was associated with liver fibro
45                             The shift toward M2 macrophage activation was confirmed in bone marrow-de
46                              Pro-tumorigenic M2 macrophage activation was diminished in myeloid-speci
47                    The alterations in M1 and M2 macrophage activation were confirmed in bone marrow-d
48 ates a mechanism by which NaCl inhibits full M2 macrophage activation.
49  well-accepted but simplified paradigm of M1/M2 macrophage activation.
50 RP-39 deficiency was found to be involved in M2 macrophage activation.
51 sociated with alternative anti-inflammatory (M2) macrophage activation, including interleukin 4 (IL-4
52 components related to interferon activation, M2 macrophages, adaptive immunity, extracellular matrix
53 -/-), which exhibit a selective depletion of M2 macrophages after MI.
54 omitant increases in alternatively activated M2 macrophage and dendritic cell phenotypes.
55 ected mice lacking A2BAR exhibited decreased M2 macrophage and eosinophil recruitment and reduced IL-
56 ment, differential expression between M1 and M2 macrophages and a validation using genes causing mono
57 ificantly increased levels of protumorigenic M2 macrophages and beta-cateninSer552 (beta-CatSer552) e
58 rrelation was observed between the number of M2 macrophages and beta-cell replication.
59  SDF-1 expressing cells, HGF expressing Ym1+ M2 macrophages and CD133+ stem cells in the injury sites
60 d invasion, elevated CD8+ T cells, decreased M2 macrophages and decreased angiogenesis.
61 cancer growth with increased tumor-promoting M2 macrophages and decreased CD8(+) T cells.
62 in D1 did not promote the differentiation of M2 macrophages and did not promote tissue fibrosis.
63 impaired recovery, associated with decreased M2 macrophages and escalated microbial imbalance.
64 t model showed reduction of tumor-associated M2 macrophages and favored polarization towards an antit
65  in accumulation of inflammation-suppressing M2 macrophages and FOXP3(+) Tregs in plaques and reduced
66        Consequently, Gpr132 deletion reduces M2 macrophages and impedes breast cancer lung metastasis
67 sponse, mediated by a decrease of protumoral M2 macrophages and increased infiltration of antitumor C
68  (M2pep) that binds preferentially to murine M2 macrophages and M2-like TAMs.
69 ic tumor microenvironment that harbored more M2 macrophages and myeloid-derived suppressor cells.
70  mice that had a depleted ability to develop M2 macrophages and other in-vitro studies supported that
71 ct and selective depletion of protumorigenic M2 macrophages and promotes antitumor immunity, highligh
72 inhibitor-loaded nanoparticles (DNTs) target M2 macrophages and simultaneously inhibit CSF1R and SHP2
73 ation of eosinophils, but markedly decreased M2 macrophages and SPEM features, while eosinophil deple
74 icant reduction in both local IL33-producing M2 macrophages and SPEM in SAMP.
75           Dab2 expression was upregulated in M2 macrophages and suppressed in M1 macrophages isolated
76 ermore, we demonstrated that the decrease in M2 macrophages and TAMs, concomitant with the reduction
77 apable of downregulating the M2 phenotype in M2 macrophages and that the low expression of this miRNA
78 atment increased parasympathetic modulation, M2 macrophages and the anti-oxidant enzyme activity but
79 ethally infected mice showed polarization of M2 macrophages and their accumulation in peritoneum, but
80 hoblast cells, is able to induce homeostatic M2 macrophages and Tregs.
81 in M1 macrophages was markedly lower than in M2 macrophages and unstimulated controls.
82 d in reduced infiltration of protumorigenic (M2) macrophages and dramatically decreased ascites volum
83 mmune cells such as alternatively activated (M2) macrophages and Th17 cells play a role in the progre
84 ription factor PPARgamma is known to promote M2-macrophage and alveolar macrophage development.
85  to 1664 +/- 349 cells/mg; P < 0.01), M1 and M2 macrophages, and dendritic cells in perivascular adip
86 s of pro-tumorigenic alternatively polarized M2 macrophages, and lower levels of several chemokines a
87 umulation of regulatory T cells, mast cells, M2 macrophages, and markedly elevated transforming growt
88 ting effector T cells, increases a subset of M2 macrophages, and significantly prolongs survival in c
89  T cells as well as alternatively activated (M2) macrophages, and the induction of pulmonary histopat
90                              In contrast, in M2 macrophages, APN induced the anti-inflammatory cytoki
91        Increased infiltration of M1, but not M2, macrophages appears to mediate the suppression of UU
92     The polarization processes for M1 versus M2 macrophages are quite distinct in the context of chan
93                                         Lung M2 macrophages are regulators of airway inflammation, as
94       Alternatively activated (also known as M2) macrophages are involved in the repair of various ty
95  stimulated naive monocytes to polarize into M2 macrophages as indicated by increased surface express
96 sion associated with alternatively activated M2 macrophages as well as expression of genes associated
97  in the PDL-tail and were mainly produced by M2 macrophages at the early stage and by activated myofi
98 the expression of Mrc1 and Chil1, markers of M2 macrophages at the MI zone.
99 ediates colonic homeostasis by modulating M1/M2 macrophage balance and preventing extensive dysbiosis
100 tions to improve our understanding of the M1-M2 macrophage balance and properly exploit it in tissue
101 mopoietic phenotype of increased circulating M2 macrophages but failed to affect plaque development.
102 A restricted the proliferation of protumoral M2 macrophages but increased the proliferation of antitu
103 containing liposomes killed activated murine M2 macrophages, but not Hut78 cells, demonstrating selec
104 12+ colon mesenchymal cells (CMCs) generated M2 macrophages by regulating their shape during recovery
105                                              M2 macrophages (CD11b+/CD206+) did not increase with RE,
106        M1 macrophages (CD86(+)), rather than M2 macrophages (CD206(+)), were the dominant macrophage
107                                 Finally, the M2 macrophage chemokine CCL17 was identified as an essen
108 ant perivascular infiltration of M1, but not M2, macrophages coincides with endothelial expression of
109 er tumor burden and infiltration of MDSC and M2 macrophages compared with LNs at other sites.
110  growth factor beta, a prominent cytokine of M2 macrophages, compared with control ISMC.
111  and contribute to the pathology of obesity, M2 macrophages contribute to the pathology of asthma, bu
112         Excessive activation of either M1 or M2 macrophages contributes to the pathology of many dise
113                                              M2 macrophages correlate with disease severity and poor
114  only increased levels of CCL18, a marker of M2 macrophages, correlate with low CD4+ T cell counts in
115 ammatory M1 to alternative anti-inflammatory M2 macrophages, could potentially display osteoclast-lik
116 red via enhanced levels of anti-inflammatory M2 macrophages coupled with an impaired sensitivity of s
117   Furthermore, it promoted the precursors of M2 macrophages, DCs and regulatory T cells.
118 ecific loss of TRPC3 showed that M1, but not M2 macrophages, deficient in Trpc3 are less susceptible
119             Importantly, a combined blocking M2 macrophage-derived factors TGF-beta, VEGF and SDF-1 a
120 han M2pepKLA to primary, bone marrow-derived M2 macrophage, desired selectivity was retained only wit
121                                 Frequency of M2 macrophages detection associated with short-term rela
122              HIF-2 expression and markers of M2 macrophage differentiation were decreased in response
123 and more glycolytic M1 phenotype, but not to M2 macrophage differentiation, which primarily relies on
124 immune responses and that it is required for M2 macrophage differentiation.
125 hat PRMT1 is necessary for c-Myc function in M2 macrophage differentiation.
126 tivated receptor gamma (PPARgamma)-dependent M2 macrophage differentiation.
127 insulin receptor substrate (IRS)-2, inducing M2 macrophage differentiation.
128     Collectively, these results suggest that M2 macrophages directly reduce the levels of HSV-1 laten
129 , whereas naive macrophages and IL-4-induced M2 macrophages do not express GLUT6 protein.
130 HA induces FoxP3 T regulatory cells in vivo, M2 macrophages drive transforming growth factor-beta and
131 tic granuloma pathology through induction of M2 macrophages during S. japonicum infection.
132  investigated, T regulatory cells and M0 and M2 macrophages emerged as the most strongly associated w
133                     miR-155 was increased in M2-macrophages except in adalimumab-treated patients.
134 ulting in higher IL-13 expression levels and M2 macrophage expansion in adipose tissue.
135 ess was established by transferring purified M2 macrophages from PAM3 treated control donors into DSS
136 ction has also been described, as well as in M2 macrophage function under defined circumstances.
137  were increased in GF-fed offspring, as were M2 macrophage gene markers and tight junction-related ge
138 e proinflammatory M1 macrophages induce T1D, M2 macrophages have been shown to delay this autoimmune
139 EPS induces development of anti-inflammatory M2 macrophages in a TLR4-dependent manner, and these cel
140 -induced IRS-2 signaling and polarization of M2 macrophages in allergic inflammation.
141        Here, we discuss the roles for M1 and M2 macrophages in asthma and obesity, and propose a mode
142 ling, leading to dysfunctions of both M1 and M2 macrophages in chronic HCV infected patients.
143              Consequently, the proportion of M2 macrophages in inflamed colons was lower in AKAP12 KO
144  miR-140 deficiency promotes accumulation of M2 macrophages in irradiated lung tissues.
145         Our data suggests an upregulation of M2 macrophages in laser treated animals by the increasin
146 , consistent with a key role of arginase and M2 macrophages in myeloma elimination by Th2 cells.
147 ed the origin and functional requirement for M2 macrophages in regression in normolipidemic mice that
148 ge recruitment and increased polarization of M2 macrophages in the arterial wall.
149                         The critical role of M2 macrophages in this process was established by transf
150                                          The M2 macrophages in turn were found to secrete high levels
151 ting the immune response toward either M1 or M2 macrophages in vivo, wild-type mice were injected wit
152 pro-inflammatory (M1) and anti-inflammatory (M2) macrophages in human breast adipose tissue, determin
153                The number of CD68(+)CD206(+) M2 macrophages increased three- to sixfold from >=6 days
154 lls, increased M1 macrophages, and decreased M2 macrophages, indicating that host Wnt5a promotes an i
155                                     Finally, M2 macrophages induced a DC-SIGN-dependent adhesion of h
156 CM) from M1 macrophages, but not from M0 and M2 macrophages, induced chemokine (C-X-C motif) ligand 1
157 eneic CD4(+) T cell activation, but promotes M2 macrophage-induced autologous and allogeneic CD4(+) T
158    These results suggest a critical role for M2 macrophage induction in chronic HCV-associated immune
159 ssion, and this was associated with impaired M2 macrophage infiltration of the primary tumors.
160  T helper type 2-skewed immune polarization, M2 macrophage infiltration, and endothelial-to-mesenchym
161  T helper type 2-skewed immune polarization, M2 macrophage infiltration, and endothelial-to-mesenchym
162   They also exhibited more adipogenesis with M2 macrophage infiltration, both of which were abolished
163                                    In vitro, M2 macrophages inhibit CD4(+) and CD8(+) T cells.
164                                              M2 macrophages, innate lymphoid type 2 cells (ILC2s), eo
165 ment of both eosinophils and IL33-expressing M2 macrophages into corpus tissues were evident in SAMP.
166  examined how the activation of alternative (M2) macrophages is affected by salt.
167 nt downstream infiltration of IL33-producing M2 macrophages leading to intestinalized SPEM in SAMP, s
168 C. innocuum stimulates tissue remodeling via M2 macrophages, leading to an adipose tissue barrier tha
169 on, and in liver sections, PRMT1, c-Myc, and M2 macrophage levels were strongly correlated with each
170                                              M2 macrophage-like TAMs were localized in the center of
171 CVc inhibits phagocytosis activity of M1 and M2 macrophages, M1 macrophage-induced autologous and all
172     Treatment with the CM from CYP4A10(high) M2 macrophages (M2) increased pre-metastatic niche forma
173 Cs suppressed cytokine production, increased M2 macrophage marker expression, and augmented phagocyti
174 diated upregulation of the anti-inflammatory M2 macrophage marker interleukin-4Ralpha (IL-4Ralpha).
175 hage marker, was decreased; while Cd206, the M2 macrophage marker, was increased in skeletal muscle o
176 ased expression of lysosomal acid lipase, an M2 macrophage marker.
177  iNos, Ip10) and promoting the expression of M2 macrophage markers (Mrc1, Arg1, Il10) in bone-marrow-
178  exhibited the lower levels of ER stress and M2 macrophage markers than those from cGVHD-affected mic
179 thin the brain and an elevated expression of M2 macrophage markers than those receiving cryptococcal-
180 CM of recovering colons and mainly expressed M2 macrophage markers.
181 hages polarize in local environments, M1 and M2 macrophages may coexist in different organs and may d
182 Gpr132 expression positively correlates with M2 macrophages, metastasis, and poor prognosis in patien
183   The seemingly opposing functions of M1 and M2 macrophages must be tightly regulated for an effectiv
184 shed an immunosuppressive milieu mediated by M2 macrophages, myeloid-derived suppressor cells, CD1d(h
185 ophages are chemotactic to chemerin, whereas M2 macrophages not expressing ChemR23 surface receptor a
186                                              M2 macrophages not only release TGFbeta1 to directly ind
187 y in the ICU is associated with an increased M2 macrophage number, increased vascular density, and an
188                        Both PRMT1 levels and M2 macrophage numbers were significantly lower in livers
189 ived monocytes and "alternatively activated" M2 macrophages obtained by interleukin 4 treatment, but
190  investigated the possible effects of M1 and M2 macrophages on RANKL-induced osteoclastogenesis.
191                                      Th2 and M2 macrophage or microglia supernatants had neither a di
192 o nonstimulated conditions (M0), addition of M2 macrophages, or no macrophage addition (P < 0.05), su
193  was associated with greater infiltration of M2 macrophages (p = 0.011) and neutrophils (p = 0.055).
194    Furthermore, VEGFC administration reduced M2 macrophage pericystic infiltrate, which has been impl
195  macrophages by 4.6% (P = 0.07), whereas the M2 macrophage phenotype increased by 46.9% (P = 0.04).
196 mor-associated macrophages (TAMs) exhibit an M2 macrophage phenotype that suppresses anti-tumor immun
197             In healing wounds, the M1 toward M2 macrophage phenotype transition supports resolution o
198 omplex, which promotes the anti-inflammatory M2 macrophage phenotype, and assists TRXR1-regulated arr
199 ppression and miR-146a induction promote the M2 macrophage phenotype, resulting in amelioration of ac
200 e, and arginase-positive cells, indicating a M2 macrophage phenotype.
201 , a biomarker of the alternatively activated M2 macrophage phenotype.
202 in human proinflammatory M1 and proresolving M2 macrophage phenotypes that, upon exposure to Escheric
203                                       M1 and M2 macrophage phenotypes, which mediate proinflammatory
204                      Alternatively activated M2 macrophages play an important role in maintenance of
205                                              M2 macrophages play an important role in tissue repair a
206  that reparative (alternatively activated or M2) macrophages play a role in repair of damaged tissues
207  inhibitors aspirin and celecoxib suppressed M2 macrophage polarization and decreased allergic airway
208 of colonic homeostasis caused by aberrant M1/M2 macrophage polarization and dysbiosis contributes to
209 IRE1alpha) as a critical switch governing M1-M2 macrophage polarization and energy balance.
210                    Increased intermediate M1-M2 macrophage polarization and improved cognition in mil
211            Ces1/Ces1g ablation also promoted M2 macrophage polarization and induced hepatic cholester
212 by reducing plaque inflammation by promoting M2 macrophage polarization and Treg induction.
213    TSP-2 knockdown induced anti-inflammatory M2 macrophage polarization at 21 d; however, it did not
214 tion of gp130 signaling leads to a defective M2 macrophage polarization followed by exacerbated infla
215 f prostaglandin E(2) (PGE(2)), which induced M2 macrophage polarization in the lung.
216 tion, enhanced type 2 cytokine signaling and M2 macrophage polarization in the subcutaneous white fat
217  for gp130 signaling in myeloid cells during M2 macrophage polarization in vitro and in vivo.
218 dendritic cell maturation and did not induce M2 macrophage polarization in vitro.
219  we examined the expression profile of 16 M1/M2 macrophage polarization markers at 3 h and 7 d postin
220 rent genes in a pattern distinct from the M1/M2 macrophage polarization paradigm.
221     Obesity shifts the immune phenotype from M2 macrophage polarization to M1, which causes metabolic
222 , lower aortic valve leaflet area, increased M2 macrophage polarization, and improved echocardiograph
223 es the activation of key pathways leading to M2 macrophage polarization, including STAT3, STAT6, Krup
224 lular communication and pro-tumoral baseline M2 macrophage polarization, the Panc-1 cells were transf
225 d spare respiratory capacity, and induced an M2 macrophage polarization-associated gene profile.
226 ory molecule gene expression and (d) induces M2 macrophage polarization.
227 minal aortic aneurysm formation and increase M2 macrophage polarization.
228 acrophage differentiation, in turn affecting M2 macrophage polarization.
229 so modulate the immune response by promoting M2 macrophage polarization.
230 ulation of Fra-1 expression and induction of M2 macrophage polarization.
231 nd thermogenesis in SAT, in part by slanting M2 macrophage polarization.
232 ulatory factor 4, a transcription factor for M2 macrophage polarization.
233             Effective therapy targeting this M2 macrophage population is thus a promising adjuvant to
234  increases regulatory T cells which activate M2 macrophages, prevent T cell proliferation and reduce
235                      In vitro data supported M2 macrophages promoting fibroblast differentiation and
236 progression of IBD whereas immunosuppressive M2 macrophages protect against colitis.
237 ted a high HC in vitro and an increase in M1/M2 macrophage ratio in vivo.
238 tors, enhanced vascularity, and decreased M1/M2 macrophage ratios may account for the enhanced tumori
239 D8(+) T-cell infiltration, (iii) enhanced M1/M2 macrophage ratios, (iv) inhibited tumor growth, (v) b
240                Conversely, anti-inflammatory M2 macrophages reduce inflammation and aid in wound heal
241  T cells, Ly6C(+) monocytes, and both M1 and M2 macrophages; reduced tubulointerstitial and glomerula
242 phages primarily rely on glycolysis, whereas M2 macrophages rely on the tricarboxylic acid cycle and
243                                    The M1 to M2 macrophage reprogramming that develops during LPS tol
244 1 macrophages are highly glycolytic, whereas M2 macrophages require a more oxidative nutrient metabol
245 67 levels in stromal cells, and a persistent M2 macrophage response through day 56.
246 ns revealed an increase in anti-inflammatory M2 macrophage responses in liver and spleen, as associat
247               As hypothesized, the number of M2 macrophages rose and disease severity decreased.
248 ation of any cytotoxic drug cargo, exhibited M2 macrophage-selective toxicity not observed in monoval
249 ariants were associated with UM risk; M1 and M2 macrophage-specific gene expression was associated wi
250                Human UM cells express M1 and M2 macrophage-specific genes, whose expression is associ
251 id A (SAA) are significantly up-regulated in M2 macrophages stimulated with IL-31, but not in IL-4 re
252 n, confocal staining for macrophages, M1 and M2 macrophage subtypes, alpha-actin, and DAPI was perfor
253 hages up-regulated markers characteristic of M2 macrophages such as CD163 and CD206.
254 ocytose tumor cells, while anti-inflammatory M2 macrophages such as tumor-associated macrophages (TAM
255 ytes to differentiate into immunosuppressive M2 macrophages, suggesting that PAM3 might be of benefit
256 e cold-induced recruitment of adipose tissue M2 macrophages, suggesting the role of CSF1R signaling i
257 T regulatory cells in vitro, and DHA-treated M2 macrophages suppress atopic dermatitis in mice.
258             We have previously identified an M2 macrophage-targeting peptide (M2pep) that binds prefe
259 s, PCTR1 levels were significantly higher in M2 macrophages than in M1 phenotype, along with members
260 xpressed inducible NO synthase and decreased M2 macrophages that expressed Arginase 1 and were found
261 , with concomitant enhancements in ILC2s and M2 macrophages that helped control adipose tissue inflam
262 rgistic activation of Arg1 by RA and IL-4 in M2 macrophages that involves feed forward regulation of
263 ymphoid cells, which promote polarization of M2 macrophages, thereby enhancing expansion of the Treg
264 0.6 cells/visual field; p < 0.05, n = 6) and M2 macrophages [though the infiltration of macrophages w
265 its monocyte differentiation to either M1 or M2 macrophages through TLR2, associated with impaired ST
266  This results in efficient repolarization of M2 macrophages to an active M1 phenotype, and superior p
267 ge arginase-1 is the only factor required by M2 macrophages to block T cells in G1, and this effect i
268                 However, the contribution of M2 macrophages to cardiac repair after myocardial infarc
269            IMD repolarizes immunosuppressive M2 macrophages to immunostimulatory M1 macrophages, whil
270 ytokines and chemokines, converted bystander M2 macrophages to M1, upregulated antigen presentation m
271 not resting (M0) or alternatively activated (M2) macrophages, to prime resting autologous NK cells.
272 et for 12 weeks showed increased circulating M2 macrophages together with a reduction in plaque forma
273 61 and MGG8 models A2V reprogrammed protumor M2 macrophages toward the antitumor M1 phenotype.
274 se (TRAP)-positive cell induction than M0 or M2 macrophage transfer.
275 g in vivo and in vitro studies, we show that M2 macrophages trigger hepatocyte senescence and enhance
276  effects were associated with an increase of M2 macrophages (twice in relation to control animals) an
277 pulmonary type 2 immune response (Th2 cells, M2 macrophages, type 2 innate lymphoid cells, IL-33, IL-
278 n and bioenergetics of in vitro models, with M2 macrophages utilizing oxidative phosphorylation (OX P
279 ionship between duration of stay in the ICU, M2 macrophages, vascularization, and pancreatic cell rep
280 irect, selective depletion of protumorigenic M2 macrophages via attenuation of CSF1 receptor signalin
281 d higher CD302 expression in mouse M1 versus M2 macrophages was also noteworthy.
282 l field; p < 0.01, n = 6), the percentage of M2 macrophages was decreased (denervated vs intact: 31 +
283                 Following EET, the change in M2 macrophages was positively associated with changes in
284 RalphaKO mice, a marked reduction of uterine M2-macrophages was detected, a cell type relevant for an
285 CSF-1 DNA, which enhances the development of M2 macrophages, was associated with reduced virus replic
286 (-/-) phenotype was in part due to increased M2 macrophages, we adoptively transferred wt macrophages
287  and selective binding of [M2pep]2-Biotin to M2 macrophages were achieved with at least 10-fold lower
288         Common lymphoid progenitor cells and M2 macrophages were found to increase in female samples
289                                       M0 and M2 macrophages were highly resistant to TKIs and maintai
290                                              M2 macrophages were increased with EGCG compared with pl
291                                 Increases in M2 macrophages were positively correlated with fiber hyp
292 of Th1/Th17 cells and the polarization of M1/M2 macrophages; whereas the systemic immune responses ap
293 umor edge causing proliferative expansion of M2 macrophages, which in turn promotes tumor growth.
294 ed to controls with a reciprocal decrease in M2 macrophages, which remained unchanged among pathologi
295 r molecule Rictor inhibits the generation of M2 macrophages while leaving the generation of classical
296 ntiated into M1 macrophages with IFNgamma or M2 macrophages with IL4.
297 y defined by the balance between M0, M1, and M2 macrophages, with distinct survival patterns by ER st
298  the 32 tested cytokines and chemokines than M2 macrophages, with HSV-1 infection significantly incre
299 focal histology demonstrated a prevalence of M2 macrophages within the aortic medium in mice treated
300 ng obese mice exhibited greater ratios of M1/M2 macrophages within the peritoneal and visceral adipos

 
Page Top